Today’s visit by Prime Minister Michael Kretschmer, part of the CDU, a party known for its critical stance on cannabis, to Grünhorn in Leipzig marks a significant milestone in the political recognition of cannabis as a plant-based medicine.
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) with the most advanced cannabinoid pharmaceutical extract portfolio, has partnered
In a landmark moment for the Greek medical cannabis industry, Tikun Olam Europe, the 1st Medical Cannabis Company in Greece, sets new standards and achieves another first by completing the 1st export of finished medical cannabis products from Greece
Over the past year, local police and sheriff’s departments have relied on faulty testing of legal hemp products. These departments are using analytical methods that the Texas Department of Public Safety official testified to in front of a legislative committee – that the analytical methods should be used to determine the legality of products sold in Texas.
CANNAVIGIA (by Vigia AG), a global pioneer in cannabis compliance software and consulting, is expanding its presence in the U.S. market, building on recent regulatory developments related to the potential rescheduling of medical cannabis to Schedule III.
Responsibility for all medical cannabis policy and regulation should sit with the Department of Health and Social Care (DHSC), according
Oxford Cannabinoid Technologies (“OCT” or “the Company”) is pleased to announce the successful completion of ‘proof of concept’ of its
The NHS is failing to prescribe cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC).
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study.
New Zealand’s largest producer of medicinal cannabis, Helius Therapeutics, has launched in the Australian market under the brand HTL. On
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.